25 XP   0   0   10

Ypsomed Holding AG
Buy, Hold or Sell?

Let's analyse Ypsomed together

PenkeI guess you are interested in Ypsomed Holding AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ypsomed Holding AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ypsomed Holding AG

I send you an email if I find something interesting about Ypsomed Holding AG.

Quick analysis of Ypsomed (30 sec.)










What can you expect buying and holding a share of Ypsomed? (30 sec.)

How much money do you get?

How much money do you get?
CHF2.65
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
CHF41.78
Expected worth in 1 year
CHF91.62
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
CHF52.23
Return On Investment
14.5%

For what price can you sell your share?

Current Price per Share
CHF360.00
Expected price per share
CHF313.00 - CHF377.00
How sure are you?
50%

1. Valuation of Ypsomed (5 min.)




Live pricePrice per Share (EOD)

CHF360.00

Intrinsic Value Per Share

CHF-42.13 - CHF21.86

Total Value Per Share

CHF-0.35 - CHF63.64

2. Growth of Ypsomed (5 min.)




Is Ypsomed growing?

Current yearPrevious yearGrowGrow %
How rich?$630m$442.1m$187.8m29.8%

How much money is Ypsomed making?

Current yearPrevious yearGrowGrow %
Making money$56.6m$25.5m$31.1m54.9%
Net Profit Margin10.3%5.0%--

How much money comes from the company's main activities?

3. Financial Health of Ypsomed (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#55 / 173

Most Revenue
#35 / 173

Most Profit
#31 / 173

What can you expect buying and holding a share of Ypsomed? (5 min.)

Welcome investor! Ypsomed's management wants to use your money to grow the business. In return you get a share of Ypsomed.

What can you expect buying and holding a share of Ypsomed?

First you should know what it really means to hold a share of Ypsomed. And how you can make/lose money.

Speculation

The Price per Share of Ypsomed is CHF360.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ypsomed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ypsomed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is CHF41.78. Based on the TTM, the Book Value Change Per Share is CHF12.46 per quarter. Based on the YOY, the Book Value Change Per Share is CHF-0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is CHF0.60 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ypsomed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 CHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per Share
Usd Eps4.151.2%4.151.2%1.870.5%2.460.7%2.580.7%
Usd Book Value Change Per Share13.763.8%13.763.8%-0.31-0.1%3.701.0%2.860.8%
Usd Dividend Per Share0.660.2%0.660.2%1.190.3%0.810.2%0.750.2%
Usd Total Gains Per Share14.424.0%14.424.0%0.870.2%4.511.3%3.611.0%
Usd Price Per Share212.54-212.54-180.07-169.35-155.71-
Price to Earnings Ratio51.21-51.21-96.29-138.87-98.36-
Price-to-Total Gains Ratio14.73-14.73-205.92-96.10-78.22-
Price to Book Ratio4.60-4.60-5.56-4.91-5.58-
Price-to-Total Gains Ratio14.73-14.73-205.92-96.10-78.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share397.692
Number of shares2
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.660.81
Usd Book Value Change Per Share13.763.70
Usd Total Gains Per Share14.424.51
Gains per Quarter (2 shares)28.859.02
Gains per Year (2 shares)115.4036.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1511010563026
211220220135962
316330335198998
42144045026119134
52755056532148170
63266168039178206
73777179545207242
84288191052237278
948991102558267314
10531101114065296350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%17.05.00.077.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.010.054.5%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.03.00.086.4%

Fundamentals of Ypsomed

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Fundamental data was last updated by Penke on 2024-03-13 21:43:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ypsomed Holding AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ypsomed earns for each CHF1 of revenue.

  • Above 10% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 10.3% means that CHF0.10 for each CHF1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ypsomed Holding AG:

  • The MRQ is 10.3%. The company is making a huge profit. +2
  • The TTM is 10.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.3%TTM10.3%0.0%
TTM10.3%YOY5.0%+5.3%
TTM10.3%5Y6.6%+3.7%
5Y6.6%10Y7.8%-1.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ10.3%6.2%+4.1%
TTM10.3%7.4%+2.9%
YOY5.0%8.0%-3.0%
5Y6.6%7.1%-0.5%
10Y7.8%7.7%+0.1%
1.1.2. Return on Assets

Shows how efficient Ypsomed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • 5.9% Return on Assets means that Ypsomed generated CHF0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ypsomed Holding AG:

  • The MRQ is 5.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.9%TTM5.9%0.0%
TTM5.9%YOY3.1%+2.9%
TTM5.9%5Y4.4%+1.6%
5Y4.4%10Y6.2%-1.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%1.2%+4.7%
TTM5.9%1.2%+4.7%
YOY3.1%1.7%+1.4%
5Y4.4%1.6%+2.8%
10Y6.2%1.6%+4.6%
1.1.3. Return on Equity

Shows how efficient Ypsomed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • 9.1% Return on Equity means Ypsomed generated CHF0.09 for each CHF1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ypsomed Holding AG:

  • The MRQ is 9.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.1%TTM9.1%0.0%
TTM9.1%YOY5.9%+3.2%
TTM9.1%5Y7.1%+2.0%
5Y7.1%10Y9.3%-2.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1%2.3%+6.8%
TTM9.1%2.6%+6.5%
YOY5.9%3.1%+2.8%
5Y7.1%3.2%+3.9%
10Y9.3%3.0%+6.3%

1.2. Operating Efficiency of Ypsomed Holding AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ypsomed is operating .

  • Measures how much profit Ypsomed makes for each CHF1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 7.5% means the company generated CHF0.07  for each CHF1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ypsomed Holding AG:

  • The MRQ is 7.5%. The company is operating less efficient.
  • The TTM is 7.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.5%TTM7.5%0.0%
TTM7.5%YOY5.2%+2.2%
TTM7.5%5Y5.8%+1.7%
5Y5.8%10Y8.4%-2.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5%8.4%-0.9%
TTM7.5%6.5%+1.0%
YOY5.2%10.7%-5.5%
5Y5.8%10.1%-4.3%
10Y8.4%8.4%0.0%
1.2.2. Operating Ratio

Measures how efficient Ypsomed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are CHF0.93 for each CHF1 in net sales.

Let's take a look of the Operating Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.925. The company is less efficient in keeping operating costs low.
  • The TTM is 0.925. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.925TTM0.9250.000
TTM0.925YOY0.948-0.022
TTM0.9255Y0.941-0.016
5Y0.94110Y0.915+0.026
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9251.099-0.174
TTM0.9251.149-0.224
YOY0.9481.109-0.161
5Y0.9411.101-0.160
10Y0.9151.055-0.140

1.3. Liquidity of Ypsomed Holding AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ypsomed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.80 means the company has CHF0.80 in assets for each CHF1 in short-term debts.

Let's take a look of the Current Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.804. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.804. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.804TTM0.8040.000
TTM0.804YOY0.816-0.011
TTM0.8045Y0.788+0.017
5Y0.78810Y1.092-0.304
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8042.385-1.581
TTM0.8042.589-1.785
YOY0.8162.582-1.766
5Y0.7882.635-1.847
10Y1.0922.614-1.522
1.3.2. Quick Ratio

Measures if Ypsomed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.52 means the company can pay off CHF0.52 for each CHF1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.521. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.521. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.521TTM0.5210.000
TTM0.521YOY0.479+0.042
TTM0.5215Y0.442+0.079
5Y0.44210Y0.598-0.156
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5211.165-0.644
TTM0.5211.172-0.651
YOY0.4791.283-0.804
5Y0.4421.392-0.950
10Y0.5981.477-0.879

1.4. Solvency of Ypsomed Holding AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ypsomed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ypsomed to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.34 means that Ypsomed assets are financed with 33.8% credit (debt) and the remaining percentage (100% - 33.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.338. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.338. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.338TTM0.3380.000
TTM0.338YOY0.471-0.133
TTM0.3385Y0.407-0.068
5Y0.40710Y0.364+0.043
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3380.353-0.015
TTM0.3380.355-0.017
YOY0.4710.358+0.113
5Y0.4070.362+0.045
10Y0.3640.369-0.005
1.4.2. Debt to Equity Ratio

Measures if Ypsomed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 51.9% means that company has CHF0.52 debt for each CHF1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ypsomed Holding AG:

  • The MRQ is 0.519. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.519. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.519TTM0.5190.000
TTM0.519YOY0.909-0.390
TTM0.5195Y0.709-0.191
5Y0.70910Y0.592+0.118
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5190.541-0.022
TTM0.5190.545-0.026
YOY0.9090.529+0.380
5Y0.7090.640+0.069
10Y0.5920.665-0.073

2. Market Valuation of Ypsomed Holding AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every CHF1 in earnings Ypsomed generates.

  • Above 15 is considered overpriced but always compare Ypsomed to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 51.21 means the investor is paying CHF51.21 for every CHF1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ypsomed Holding AG:

  • The EOD is 95.827. Based on the earnings, the company is expensive. -2
  • The MRQ is 51.214. Based on the earnings, the company is expensive. -2
  • The TTM is 51.214. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD95.827MRQ51.214+44.613
MRQ51.214TTM51.2140.000
TTM51.214YOY96.288-45.074
TTM51.2145Y138.870-87.656
5Y138.87010Y98.357+40.513
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD95.82717.039+78.788
MRQ51.21417.929+33.285
TTM51.21419.435+31.779
YOY96.28820.661+75.627
5Y138.87021.503+117.367
10Y98.35727.130+71.227
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ypsomed Holding AG:

  • The EOD is -123.948. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -66.243. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -66.243. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-123.948MRQ-66.243-57.705
MRQ-66.243TTM-66.2430.000
TTM-66.243YOY-53.320-12.923
TTM-66.2435Y-44.466-21.777
5Y-44.46610Y-3.471-40.994
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-123.94810.083-134.031
MRQ-66.2439.744-75.987
TTM-66.2431.298-67.541
YOY-53.3204.667-57.987
5Y-44.4664.114-48.580
10Y-3.4710.108-3.579
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ypsomed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 4.60 means the investor is paying CHF4.60 for each CHF1 in book value.

Let's take a look of the Price to Book Ratio trends of Ypsomed Holding AG:

  • The EOD is 8.616. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.605. Based on the equity, the company is fair priced.
  • The TTM is 4.605. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD8.616MRQ4.605+4.011
MRQ4.605TTM4.6050.000
TTM4.605YOY5.558-0.953
TTM4.6055Y4.908-0.303
5Y4.90810Y5.583-0.675
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD8.6162.522+6.094
MRQ4.6052.733+1.872
TTM4.6052.706+1.899
YOY5.5583.220+2.338
5Y4.9083.824+1.084
10Y5.5834.219+1.364
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ypsomed Holding AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--12.45812.4580%-0.283+102%3.352+272%2.586+382%
Book Value Per Share--41.78541.7850%29.327+42%31.342+33%25.782+62%
Current Ratio--0.8040.8040%0.816-1%0.788+2%1.092-26%
Debt To Asset Ratio--0.3380.3380%0.471-28%0.407-17%0.364-7%
Debt To Equity Ratio--0.5190.5190%0.909-43%0.709-27%0.592-12%
Dividend Per Share--0.6000.6000%1.075-44%0.732-18%0.680-12%
Eps--3.7573.7570%1.693+122%2.228+69%2.339+61%
Free Cash Flow Per Share---2.904-2.9040%-3.057+5%-3.824+32%-1.289-56%
Free Cash Flow To Equity Per Share---2.812-2.8120%-0.264-91%-1.130-60%-0.448-84%
Gross Profit Margin---0.503-0.5030%-1.873+272%-3.751+646%-2.277+353%
Intrinsic Value_10Y_max--21.857--------
Intrinsic Value_10Y_min---42.132--------
Intrinsic Value_1Y_max---0.540--------
Intrinsic Value_1Y_min---3.964--------
Intrinsic Value_3Y_max--0.458--------
Intrinsic Value_3Y_min---12.205--------
Intrinsic Value_5Y_max--3.965--------
Intrinsic Value_5Y_min---20.704--------
Market Cap4913532000.000+47%2626009880.0002626009880.0000%2224738100.000+18%2092345710.000+26%1923784265.000+37%
Net Profit Margin--0.1030.1030%0.050+107%0.066+56%0.078+32%
Operating Margin--0.0750.0750%0.052+43%0.058+28%0.084-10%
Operating Ratio--0.9250.9250%0.948-2%0.941-2%0.915+1%
Pb Ratio8.616+47%4.6054.6050%5.558-17%4.908-6%5.583-18%
Pe Ratio95.827+47%51.21451.2140%96.288-47%138.870-63%98.357-48%
Price Per Share360.000+47%192.400192.4000%163.000+18%153.300+26%140.950+37%
Price To Free Cash Flow Ratio-123.948-87%-66.243-66.2430%-53.320-20%-44.466-33%-3.471-95%
Price To Total Gains Ratio27.570+47%14.73514.7350%205.918-93%96.103-85%78.223-81%
Quick Ratio--0.5210.5210%0.479+9%0.442+18%0.598-13%
Return On Assets--0.0590.0590%0.031+95%0.044+37%0.062-3%
Return On Equity--0.0910.0910%0.059+55%0.071+29%0.093-2%
Total Gains Per Share--13.05813.0580%0.792+1550%4.084+220%3.266+300%
Usd Book Value--630020352.300630020352.3000%442188211.300+42%472564147.200+33%388727580.440+62%
Usd Book Value Change Per Share--13.76213.7620%-0.313+102%3.703+272%2.857+382%
Usd Book Value Per Share--46.16046.1600%32.398+42%34.623+33%28.481+62%
Usd Dividend Per Share--0.6630.6630%1.187-44%0.809-18%0.752-12%
Usd Eps--4.1504.1500%1.870+122%2.462+69%2.583+61%
Usd Free Cash Flow---43792517.400-43792517.4000%-46092502.800+5%-57655397.700+32%-19434434.750-56%
Usd Free Cash Flow Per Share---3.209-3.2090%-3.377+5%-4.224+32%-1.424-56%
Usd Free Cash Flow To Equity Per Share---3.106-3.1060%-0.291-91%-1.249-60%-0.495-84%
Usd Market Cap5427978800.400+47%2900953114.4362900953114.4360%2457668179.070+18%2311414305.837+26%2125204477.546+37%
Usd Price Per Share397.692+47%212.544212.5440%180.066+18%169.351+26%155.707+37%
Usd Profit--56643492.50056643492.5000%25524093.500+122%33596357.340+69%35260146.010+61%
Usd Revenue--549544062.000549544062.0000%513509852.700+7%489158066.840+12%440716861.370+25%
Usd Total Gains Per Share--14.42514.4250%0.874+1550%4.512+220%3.608+300%
 EOD+5 -3MRQTTM+0 -0YOY+29 -75Y+30 -610Y+21 -15

3.2. Fundamental Score

Let's check the fundamental score of Ypsomed Holding AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1595.827
Price to Book Ratio (EOD)Between0-18.616
Net Profit Margin (MRQ)Greater than00.103
Operating Margin (MRQ)Greater than00.075
Quick Ratio (MRQ)Greater than10.521
Current Ratio (MRQ)Greater than10.804
Debt to Asset Ratio (MRQ)Less than10.338
Debt to Equity Ratio (MRQ)Less than10.519
Return on Equity (MRQ)Greater than0.150.091
Return on Assets (MRQ)Greater than0.050.059
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Ypsomed Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.394
Ma 20Greater thanMa 50360.000
Ma 50Greater thanMa 100340.300
Ma 100Greater thanMa 200315.335
OpenGreater thanClose365.000
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in CHF. All numbers in thousands.

Summary
Total Assets861,879
Total Liabilities291,570
Total Stockholder Equity562,333
 As reported
Total Liabilities 291,570
Total Stockholder Equity+ 562,333
Total Assets = 861,879

Assets

Total Assets861,879
Total Current Assets208,327
Long-term Assets653,552
Total Current Assets
Cash And Cash Equivalents 24,477
Short-term Investments 747
Net Receivables 109,026
Inventory 59,024
Other Current Assets 15,053
Total Current Assets  (as reported)208,327
Total Current Assets  (calculated)208,327
+/-0
Long-term Assets
Property Plant Equipment 379,587
Intangible Assets 231,738
Other Assets 31,498
Long-term Assets  (as reported)653,552
Long-term Assets  (calculated)642,823
+/- 10,729

Liabilities & Shareholders' Equity

Total Current Liabilities258,988
Long-term Liabilities32,582
Total Stockholder Equity562,333
Total Current Liabilities
Short-term Debt 157,000
Short Long Term Debt 157,000
Accounts payable 19,620
Other Current Liabilities 58,450
Total Current Liabilities  (as reported)258,988
Total Current Liabilities  (calculated)392,070
+/- 133,082
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt-157,000
Deferred Long Term Liability 201,239
Long-term Liabilities  (as reported)32,582
Long-term Liabilities  (calculated)44,239
+/- 11,657
Total Stockholder Equity
Common Stock193,144
Retained Earnings 188,801
Accumulated Other Comprehensive Income 180,555
Other Stockholders Equity -167
Total Stockholder Equity (as reported)562,333
Total Stockholder Equity (calculated)562,333
+/-0
Other
Capital Stock193,144
Cash And Equivalents-1
Cash and Short Term Investments 25,224
Common Stock Shares Outstanding 13,419
Current Deferred Revenue23,918
Liabilities and Stockholders Equity 861,879
Net Debt 132,523
Net Invested Capital 719,331
Net Tangible Assets 531,834
Net Working Capital -50,661
Property Plant and Equipment Gross 733,186
Short Long Term Debt Total 157,000



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-31
> Total Assets 
117,117
142,962
500,783
658,482
665,699
622,789
638,230
632,216
662,010
674,632
327,272
341,793
354,528
361,211
388,871
421,800
500,239
587,748
678,240
717,683
756,910
861,879
861,879756,910717,683678,240587,748500,239421,800388,871361,211354,528341,793327,272674,632662,010632,216638,230622,789665,699658,482500,783142,962117,117
   > Total Current Assets 
44,790
61,078
93,313
207,076
218,767
161,541
144,164
98,461
100,152
107,385
94,604
108,731
114,584
123,498
148,363
175,378
218,311
178,789
189,890
185,141
193,584
208,327
208,327193,584185,141189,890178,789218,311175,378148,363123,498114,584108,73194,604107,385100,15298,461144,164161,541218,767207,07693,31361,07844,790
       Cash And Cash Equivalents 
1,932
3,893
12,616
55,985
65,668
40,724
38,291
8,990
8,065
5,022
9,735
9,613
16,164
16,243
25,507
38,884
32,111
12,083
12,166
18,147
15,859
24,477
24,47715,85918,14712,16612,08332,11138,88425,50716,24316,1649,6139,7355,0228,0658,99038,29140,72465,66855,98512,6163,8931,932
       Short-term Investments 
0
0
0
0
41,238
25,478
0
2,295
0
0
0
0
0
0
0
0
0
-47,361
10,168
4,264
1,179
747
7471,1794,26410,168-47,3610000000002,295025,47841,2380000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
35,000
45,436
52,796
63,728
98,637
101,156
91,354
84,900
95,488
109,026
109,02695,48884,90091,354101,15698,63763,72852,79645,43635,000000000000000
       Inventory 
24,725
30,735
37,703
34,602
44,140
37,549
43,768
44,250
46,800
51,576
50,147
56,573
52,231
51,781
49,095
48,320
59,284
52,412
61,530
64,882
70,386
59,024
59,02470,38664,88261,53052,41259,28448,32049,09551,78152,23156,57350,14751,57646,80044,25043,76837,54944,14034,60237,70330,73524,725
       Other Current Assets 
18,133
26,450
42,994
116,489
67,721
57,790
62,105
42,926
45,287
50,787
34,722
42,545
46,189
55,474
73,761
88,174
126,916
13,138
14,672
12,948
10,672
15,053
15,05310,67212,94814,67213,138126,91688,17473,76155,47446,18942,54534,72250,78745,28742,92662,10557,79067,721116,48942,99426,45018,133
   > Long-term Assets 
72,327
81,884
407,470
451,406
446,932
461,248
494,066
533,755
561,858
567,247
232,668
233,062
239,944
237,713
240,508
246,422
281,928
408,959
488,350
532,542
563,326
653,552
653,552563,326532,542488,350408,959281,928246,422240,508237,713239,944233,062232,668567,247561,858533,755494,066461,248446,932451,406407,47081,88472,327
       Property Plant Equipment 
0
0
101,570
145,899
133,648
146,343
166,368
182,933
186,273
179,052
166,361
161,686
160,437
150,946
153,752
158,615
192,314
268,644
300,712
326,197
327,945
379,587
379,587327,945326,197300,712268,644192,314158,615153,752150,946160,437161,686166,361179,052186,273182,933166,368146,343133,648145,899101,57000
       Goodwill 
0
0
0
0
313,731
313,753
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000313,753313,7310000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
9,000
8,591
8,151
10,378
10,196
8,723
0
0
0
0
00008,72310,19610,3788,1518,5919,000000000000000
       Intangible Assets 
779
832
300,579
300,810
-11,992
-12,266
325,851
341,515
352,327
361,544
50,191
55,141
61,296
69,007
72,978
73,575
77,139
81,419
102,516
160,728
190,779
231,738
231,738190,779160,728102,51681,41977,13973,57572,97869,00761,29655,14150,191361,544352,327341,515325,851-12,266-11,992300,810300,579832779
       Long-term Assets Other 
70,948
79,931
142
231
41,363
25,600
406
6,990
20,686
22,660
9,053
8,338
9,376
8,591
8,151
10,377
10,195
-1
0
3,091
1
8,090
8,09013,0910-110,19510,3778,1518,5919,3768,3389,05322,66020,6866,99040625,60041,36323114279,93170,948
> Total Liabilities 
21,539
31,279
488,943
301,310
261,685
232,761
220,651
195,185
124,267
136,576
109,270
124,419
126,366
120,574
121,035
120,005
158,697
208,944
292,894
313,541
356,631
291,570
291,570356,631313,541292,894208,944158,697120,005121,035120,574126,366124,419109,270136,576124,267195,185220,651232,761261,685301,310488,94331,27921,539
   > Total Current Liabilities 
16,517
23,229
33,254
65,468
50,303
40,551
48,056
43,391
77,953
100,742
90,895
101,367
103,037
100,628
105,325
103,006
142,453
187,883
276,003
272,377
237,336
258,988
258,988237,336272,377276,003187,883142,453103,006105,325100,628103,037101,36790,895100,74277,95343,39148,05640,55150,30365,46833,25423,22916,517
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
46,500
64,500
62,500
56,000
34,000
27,000
49,000
112,000
182,999
182,500
157,000
157,000
157,000157,000182,500182,999112,00049,00027,00034,00056,00062,50064,50046,5000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
20,000
71,000
5,000
27,000
49,000
112,000
182,999
182,500
157,000
157,000
157,000157,000182,500182,999112,00049,00027,0005,00071,00020,000000000000000
       Accounts payable 
8,242
8,232
12,491
18,445
13,499
11,404
16,914
35,266
13,292
13,080
13,461
16,659
15,928
15,484
19,968
21,956
31,916
19,348
24,044
34,553
17,386
19,620
19,62017,38634,55324,04419,34831,91621,95619,96815,48415,92816,65913,46113,08013,29235,26616,91411,40413,49918,44512,4918,2328,242
       Other Current Liabilities 
8,275
14,997
20,763
47,023
36,804
29,147
31,142
8,125
64,661
87,662
30,934
20,208
24,609
29,144
51,357
54,050
61,537
49,872
57,043
35,942
43,406
58,450
58,45043,40635,94257,04349,87261,53754,05051,35729,14424,60920,20830,93487,66264,6618,12531,14229,14736,80447,02320,76314,9978,275
   > Long-term Liabilities 
5,022
8,050
455,689
235,842
211,382
192,210
172,595
151,794
46,314
35,834
18,375
23,052
23,329
19,946
15,710
16,999
16,244
21,061
16,891
41,164
119,295
32,582
32,582119,29541,16416,89121,06116,24416,99915,71019,94623,32923,05218,37535,83446,314151,794172,595192,210211,382235,842455,6898,0505,022
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,057
10,000
10,000
10,000
32,500
110,000
0
0110,00032,50010,00010,00010,00010,057000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,946
5,710
6,999
6,244
11,061
14,578
17,421
17,034
0
017,03417,42114,57811,0616,2446,9995,7104,9460000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
59,000
65,227
68,496
68,306
68,748
73,169
91,316
124,862
156,537
201,239
201,239156,537124,86291,31673,16968,74868,30668,49665,22759,000000000000000
> Total Stockholder Equity
95,578
111,683
11,840
357,172
404,014
390,028
417,579
437,031
537,743
538,056
218,003
217,374
228,162
240,637
267,836
301,796
341,542
378,804
377,659
395,385
392,540
562,333
562,333392,540395,385377,659378,804341,542301,796267,836240,637228,162217,374218,003538,056537,743437,031417,579390,028404,014357,17211,840111,68395,578
   Common Stock
0
0
250
140,553
130,433
116,378
116,378
109,631
182,156
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
178,994
193,144
193,144178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994178,994182,156109,631116,378116,378130,433140,55325000
   Retained Earnings 
5,776
12,061
11,590
39,195
106,434
109,175
26,583
26,166
0
0
191,839
193,485
207,093
226,488
262,300
308,547
360,607
420,743
112,193
116,744
132,516
188,801
188,801132,516116,744112,193420,743360,607308,547262,300226,488207,093193,485191,8390026,16626,583109,175106,43439,19511,59012,0615,776
   Capital Surplus 0000000000000000000000
   Treasury Stock00-956-6,595-6,595-6,595-3,090000000000000000
   Other Stockholders Equity 
89,802
0
0
177,424
167,147
164,475
274,618
301,234
523,465
530,713
31,365
26,648
31,098
40,555
41,305
40,208
36,701
31,576
-6,595
-957
0
-167
-1670-957-6,59531,57636,70140,20841,30540,55531,09826,64831,365530,713523,465301,234274,618164,475167,147177,4240089,802



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue497,460
Cost of Revenue-356,869
Gross Profit140,591140,591
 
Operating Income (+$)
Gross Profit140,591
Operating Expense-103,293
Operating Income37,29837,298
 
Operating Expense (+$)
Research Development28,953
Selling General Administrative26,219
Selling And Marketing Expenses77,074
Operating Expense103,293132,246
 
Net Interest Income (+$)
Interest Income23
Interest Expense-2,310
Other Finance Cost-0
Net Interest Income-2,287
 
Pretax Income (+$)
Operating Income37,298
Net Interest Income-2,287
Other Non-Operating Income Expenses0
Income Before Tax (EBT)56,63717,959
EBIT - interestExpense = 34,988
56,637
53,585
Interest Expense2,310
Earnings Before Interest and Taxes (EBIT)37,29858,947
Earnings Before Interest and Taxes (EBITDA)115,858
 
After tax Income (+$)
Income Before Tax56,637
Tax Provision-5,362
Net Income From Continuing Ops51,27551,275
Net Income51,275
Net Income Applicable To Common Shares51,275
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses460,162
Total Other Income/Expenses Net19,3392,287
 

Technical Analysis of Ypsomed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ypsomed. The general trend of Ypsomed is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ypsomed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ypsomed Holding AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 373.00 < 377.00.

The bearish price targets are: 340.50 > 327.50 > 313.00.

Tweet this
Ypsomed Holding AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ypsomed Holding AG. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ypsomed Holding AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ypsomed Holding AG. The current macd is 4.06434644.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ypsomed price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ypsomed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ypsomed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ypsomed Holding AG Daily Moving Average Convergence/Divergence (MACD) ChartYpsomed Holding AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ypsomed Holding AG. The current adx is 21.49.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ypsomed shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Ypsomed Holding AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ypsomed Holding AG. The current sar is 340.50.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ypsomed Holding AG Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ypsomed Holding AG. The current rsi is 55.39. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Ypsomed Holding AG Daily Relative Strength Index (RSI) ChartYpsomed Holding AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ypsomed Holding AG. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ypsomed price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ypsomed Holding AG Daily Stochastic Oscillator ChartYpsomed Holding AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ypsomed Holding AG. The current cci is 43.42.

Ypsomed Holding AG Daily Commodity Channel Index (CCI) ChartYpsomed Holding AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ypsomed Holding AG. The current cmo is 7.20544779.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ypsomed Holding AG Daily Chande Momentum Oscillator (CMO) ChartYpsomed Holding AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ypsomed Holding AG. The current willr is -46.57534247.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ypsomed is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ypsomed Holding AG Daily Williams %R ChartYpsomed Holding AG Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ypsomed Holding AG.

Ypsomed Holding AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ypsomed Holding AG. The current atr is 10.18.

Ypsomed Holding AG Daily Average True Range (ATR) ChartYpsomed Holding AG Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ypsomed Holding AG. The current obv is 822,811.

Ypsomed Holding AG Daily On-Balance Volume (OBV) ChartYpsomed Holding AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ypsomed Holding AG. The current mfi is 70.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ypsomed Holding AG Daily Money Flow Index (MFI) ChartYpsomed Holding AG Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ypsomed Holding AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Ypsomed Holding AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ypsomed Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.394
Ma 20Greater thanMa 50360.000
Ma 50Greater thanMa 100340.300
Ma 100Greater thanMa 200315.335
OpenGreater thanClose365.000
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ypsomed with someone you think should read this too:
  • Are you bullish or bearish on Ypsomed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ypsomed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ypsomed Holding AG

I send you an email if I find something interesting about Ypsomed Holding AG.


Comments

How you think about this?

Leave a comment

Stay informed about Ypsomed Holding AG.

Receive notifications about Ypsomed Holding AG in your mailbox!